Cannabicyclohexanol (CP 47,497 dimethyloctyl homologue, (C8)-CP 47,497) is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On the 19th of January 2009, the University of Freiburg in Germany announced that an analog of CP 47,497 was the main active ingredient in the herbal "incense" product Spice, specifically the 1,1-dimethyloctyl homologue of CP 47,497, which is now known as cannabicyclohexanol.[2][3][4][5] The 1,1-dimethyloctyl homologue of CP 47,497 is in fact several times more potent than the parent compound,[6] which is somewhat unexpected as the 1,1-dimethylheptyl is the most potent substituent in classical cannabinoid compounds such as HU-210.[7]
wikipedia source: http://en.wikipedia.org/wiki/Cannabicyclohexanol
Showing posts with label Cannabicyclohexanol. Show all posts
Showing posts with label Cannabicyclohexanol. Show all posts
Sunday, April 17, 2011
Thursday, February 17, 2011
Cannabicyclohexanol
Cannabicyclohexanol
IUPAC - 2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methylnonan-2-yl) phenol
Synthetic cannabinoid receptor agonist developed by Pfizer in 1979.
IUPAC - 2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methylnonan-2-yl) phenol
Synthetic cannabinoid receptor agonist developed by Pfizer in 1979.
CB1 receptor Kd 2.1 nM.
Active ingredient in "Spice" along with JWH-018, JWH-073, or HU-210.
Subscribe to:
Posts (Atom)